Armistice Capital’s Radiopharm Theranostics RADX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$729K Buy
+450,000
New +$1.26M 0.01% 187

Other funds holding RADX

Armistice Capital's RADX Position: Q3 2026 in Review

Armistice Capital opened a new position in Radiopharm Theranostics (RADX) in Q3 2026: 450,000 shares worth $729K. The stake represents 0.01% of the portfolio and ranks #187 among its holdings.

8 funds tracked by Wall St. Rank hold RADX as of Q3 2026.

  • Armistice Capital held 450,000 shares of Radiopharm Theranostics worth $729K as of Q3 2026.
  • Radiopharm Theranostics was a new Armistice Capital position in Q3 2026.
  • Radiopharm Theranostics made up 0.01% of Armistice Capital's portfolio in Q3 2026, its #187 holding.
  • 8 funds tracked by Wall St. Rank held Radiopharm Theranostics as of Q3 2026.

Based on Armistice Capital's 13F filing for Q3 2026, filed 16 Nov 2026.